Management of perihilar cholangiocarcinoma in the era of multimodal therapy
- 1 August 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 6 (4) , 481-495
Abstract
Perihilar cholangiocarcinoma (CCA) is the second most common primary malignant tumor of the liver. In the USA, there are approximately 3000 cases of CCA diagnosed annually, with approximately 50–70...Keywords
This publication has 136 references indexed in Scilit:
- Surgical resection for hilar cholangiocarcinoma: experience improves resectabilityHPB, 2012
- Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinomaBritish Journal of Cancer, 2012
- Hilar CholangiocarcinomaArchives of Surgery, 2011
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialBritish Journal of Cancer, 2009
- Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control StudyClinical Gastroenterology and Hepatology, 2007
- CholangiocarcinomaAnnals of Surgery, 2007
- Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trialsBritish Journal of Cancer, 2007
- Cholangiocarcinoma: Modern advances in understanding a deadly old diseaseJournal of Hepatology, 2006
- Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinomaJournal of Hepatology, 2006